VF
RIGL icon

Virtu Financial’s Rigel Pharmaceuticals RIGL Stock Holding History

Virtu Financial’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,628
Closed -$541K – 2196
2025
Q4 		$541K Sell
12,628
-7,329
-37% -$276K 0.02% 567
2025
Q3 		$565K Buy
+19,957
New +$597K 0.03% 510
2023
Q3 		– Sell
-5,029
Closed -$65K – 1791
2023
Q2 		$65K Buy
+5,029
New +$68K 0.01% 1101
2022
Q3 		– Sell
-24,523
Closed -$277K – 2153
2022
Q2 		$277K Buy
+24,523
New +$493K 0.02% 615
2021
Q2 		– Sell
-3,846
Closed -$132K – 1986
2021
Q1 		$132K Buy
+3,846
New +$152K 0.01% 1228
2020
Q4 		– Sell
-4,564
Closed -$110K – 1736
2020
Q3 		$110K Buy
4,564
+910
+25% +$22.3K 0.02% 704
2020
Q2 		$67K Buy
+3,654
New +$65.7K 0.01% 960
2019
Q3 		– Sell
-2,580
Closed -$67K – 1772
2019
Q2 		$67K Buy
2,580
+771
+43% +$17.4K ﹤0.01% 1200
2019
Q1 		$46K Sell
1,809
-4,709
-72% -$108K ﹤0.01% 1225
2018
Q4 		$150K Sell
6,518
-3,643
-36% -$103K 0.01% 1036
2018
Q3 		$326K Buy
+10,161
New +$305K 0.02% 812

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial's RIGL Position: Q1 2026 in Review

Virtu Financial sold out of Rigel Pharmaceuticals (RIGL) in Q1 2026, closing a stake of 12,628 shares — an estimated $541K sold.

Virtu Financial first reported a position in RIGL in Q3 2018 and held it in 11 quarters. The position peaked at $565K in Q3 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Virtu Financial reported no remaining Rigel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 12,628 Rigel Pharmaceuticals shares in Q1 2026, an estimated $541K.
  • Virtu Financial first reported a position in Rigel Pharmaceuticals in Q3 2018 and held it in 11 quarters.
  • Virtu Financial's Rigel Pharmaceuticals position peaked at $565K in Q3 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.